Impact of RDI for lenalidomide. (A) DOR, and (B) PFS according to RDI for lenalidomide in the efficacy and (C) ITT cohorts. CR, complete response; PR, partial response; SD, stable disease; PD, progression of disease.
Figure 2.

Impact of RDI for lenalidomide. (A) DOR, and (B) PFS according to RDI for lenalidomide in the efficacy and (C) ITT cohorts. CR, complete response; PR, partial response; SD, stable disease; PD, progression of disease.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal